TIFF 2017 Review: “Living Proof” (2017) ★★★

What is the difference between drug dealers and pharmaceutical corporations? First drug can kill anyone or turn someone into an addict, which is the same thing, while the second one still can kill, but it won’t provide necessary medicine. Every day there are many people who die from MS (multiple sclerosis) or from any type of cancer. Only a few survive. Some do because they are very lucky or have enough money to buy the most expensive treatment. But what happens if someone is a regular person that has nothing to do with medical education but is capable of finding something that might cure or even slow down the progress of MS, for instance?

That sounds too good to be true though. But there is a problem: how will the money making machine, such as MS Society or pharmaceutical companies react to it when all of a sudden patients will turn their attention from medical treatment to non-medical treatment? Exactly! Because one will lose money, while another one will get an opportunity to buy a few extra years more without spending a dollar. And that is not profitable for any one who produces so-called medicine that won’t provide a long term solution, but rather killing slowly.

Matt Embry, a writer and a director of Living Proof back in 1995, when he was 19-years-old and too young to cope with major challenge of life, finds himself diagnosed with Multiple Sclerosis. 20 years later, he still looks healthy and strong due to the diet that his father, a geologist, put him into. Releasing himself from damaging and useless treatment from MS Society, Matt and his father sent their findings to the MS Society of Canada who simply ignored the fact of helpful and clearly effective diet that can allow MS patients to continue living their life, maybe not to the fullest, but way better than the one they could have had with the same medicine which was sold to them by the pharmaceutical corporations.

From Dr. Paolo Zamboni, the audience will learn that the majority of MS patients he examined had dangerous blockages in their jugular veins, a condition known as CCSVI. But the challenge is Dr. Zamboni is not able to get funding to extend his research, and moreover is at high risk losing his license if he continues providing treatment that works. Funny, isn’t it. But that’s alright if you feel you want to get angry. Because I was and still am. But when another specialists know how to treat CCSVI effectively and with visible sign of improvement in MS patients, the same treatment was forbidden for unknown reasons. But let’s not forget we all can draw our conclusion from it, isn’t it?

Matt’s struggle, which should have never happened in the first place, continues when the MS Society of Canada started focusing on wrong things such us the design of Matt’s website, www.mshope.com rather than on a diet he provided that could benefit every MS patient.


%d bloggers like this: